World's Best Scientists 2026 revealed!
Thomas M. MacDonald

Thomas M. MacDonald

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 86 14115 13291 1303 1247 532 27676

Thomas M. MacDonald publications per year

The chart shows the history of publications by Thomas M. MacDonald between 1986 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Thomas M. MacDonald published across 40 years, from 1986 to 2025, averaging 14.5 papers a year. Output peaked at 38 publications in 1999. 23 of the 578 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1986 to 2025. Vertical axis: number of publications, 0 to 38. Peak 38 publications in 1999. 1986: 3 publications 1987: 2 publications 1988: 6 publications 1989: 5 publications 1990: 4 publications 1991: 6 publications 1992: 1 publication 1993: 3 publications 1994: 14 publications 1995: 28 publications 1996: 18 publications 1997: 29 publications 1998: 25 publications 1999: 38 publications 2000: 34 publications 2001: 24 publications 2002: 24 publications 2003: 12 publications 2004: 14 publications 2005: 9 publications 2006: 9 publications 2007: 16 publications 2008: 10 publications 2009: 15 publications 2010: 15 publications 2011: 15 publications 2012: 26 publications 2013: 12 publications 2014: 14 publications 2015: 13 publications 2016: 10 publications 2017: 9 publications 2018: 14 publications 2019: 11 publications 2020: 9 publications 2021: 32 publications 2022: 13 publications 2023: 13 publications 2024: 13 publications 2025: 10 publications
1986 2025

578 publications in total across all disciplines

View publications per year as a table
Thomas M. MacDonald: publications per year, 1986 to 2025
Year Publications
1986 3
1987 2
1988 6
1989 5
1990 4
1991 6
1992 1
1993 3
1994 14
1995 28
1996 18
1997 29
1998 25
1999 38
2000 34
2001 24
2002 24
2003 12
2004 14
2005 9
2006 9
2007 16
2008 10
2009 15
2010 15
2011 15
2012 26
2013 12
2014 14
2015 13
2016 10
2017 9
2018 14
2019 11
2020 9
2021 32
2022 13
2023 13
2024 13
2025 10
Total 578
Download as CSV

Thomas M. MacDonald publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Thomas M. MacDonald sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 521–540 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 532 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610 532
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Thomas M. MacDonald D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas M. MacDonald sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 86–87 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 86 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960 86
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Diabetes mellitus

His scientific interests lie mostly in Internal medicine, Cohort study, Surgery, Epidemiology and Endocrinology. His Internal medicine research incorporates themes from Diabetes mellitus and Cardiology. Thomas M. MacDonald combines subjects such as Relative risk, Clinical trial, Retrospective cohort study and Hazard ratio with his study of Cohort study.

His work deals with themes such as Meta-analysis, Lower risk, Poisson regression and Pioglitazone, which intersect with Surgery. The study incorporates disciplines such as Incidence and Etiology in addition to Epidemiology. His work in the fields of Endocrinology, such as Renin–angiotensin system, intersects with other areas such as Context.

His most cited work include:

  • Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. (538 citations)
  • Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial (528 citations)
  • Association of road-traffic accidents with benzodiazepine use (474 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Blood pressure, Cardiology, Surgery and Endocrinology. His work on Internal medicine is being expanded to include thematically relevant topics such as Diabetes mellitus. Thomas M. MacDonald has included themes like Ambulatory, Anesthesia and Placebo in his Blood pressure study.

His research in Surgery intersects with topics in Epidemiology and Myocardial infarction. In his work, Pediatrics is strongly intertwined with Incidence, which is a subfield of Epidemiology. His Cohort study research integrates issues from Proportional hazards model and Hazard ratio.

He most often published in these fields:

  • Internal medicine (56.40%)
  • Blood pressure (18.80%)
  • Cardiology (17.40%)

What were the highlights of his more recent work (between 2014-2021)?

  • Internal medicine (56.40%)
  • Blood pressure (18.80%)
  • Clinical trial (5.80%)

In recent papers he was focusing on the following fields of study:

Thomas M. MacDonald mainly investigates Internal medicine, Blood pressure, Clinical trial, Hazard ratio and Randomized controlled trial. His Internal medicine study which covers Cardiology that intersects with Uric acid. His Blood pressure research includes elements of Diabetes mellitus, Spironolactone, Placebo and Urology.

His study on Clinical trial also encompasses disciplines like

  • Morning which intersects with area such as Physical therapy and Primary care,
  • Dosing and related Pediatrics,
  • Ambulatory blood pressure, Drug, Alternative medicine and Public health most often made with reference to Intensive care medicine. As a member of one scientific family, Thomas M. MacDonald mostly works in the field of Hazard ratio, focusing on Proportional hazards model and, on occasion, Clostridium difficile, Stool test, Campylobacter and Bacterial Gastroenteritis. His Randomized controlled trial research is multidisciplinary, incorporating perspectives in Amlodipine, Tolerability, Combination therapy and Prospective cohort study.

Between 2014 and 2021, his most popular works were:

  • Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial (528 citations)
  • Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis (112 citations)
  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies (81 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Diabetes mellitus

Internal medicine, Blood pressure, Hazard ratio, Clinical endpoint and Spironolactone are his primary areas of study. Internal medicine is closely attributed to Cardiology in his research. His work is dedicated to discovering how Blood pressure, Urology are connected with Diuretic and Hydrochlorothiazide and other disciplines.

Within one scientific family, he focuses on topics pertaining to Proportional hazards model under Hazard ratio, and may sometimes address concerns connected to Dutasteride. His Clinical endpoint study also includes fields such as

  • Myocardial infarction, Emergency medicine and Surgery most often made with reference to Stroke,
  • Allopurinol that connect with fields like Risk factor, Febuxostat, Prospective cohort study, Gout and Record linkage. His biological study spans a wide range of topics, including Bisoprolol and Placebo, Crossover study.

Best Publications

  • Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

    Bryan Williams;Thomas M MacDonald;Steve Morant;David J Webb

  • Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease.

    Li Wei;Thomas M. MacDonald;Brian R. Walker

  • Association of road-traffic accidents with benzodiazepine use

    F. Barbone;F. Barbone;A. D. McMahon;P. G. Davey;Andrew Morris

  • Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes mellitus

    Andrew D Morris;Douglas I R Boyle;Alex D McMahon;Stephen A Greene

  • Effect of ibuprofen on cardioprotective effect of aspirin

    TM MacDonald;L Wei

  • Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study.

    P. T. Donnan;T. M. MacDonald;A. D. Morris

  • Primary non-compliance with prescribed medication in primary care.

    P. H. G. Beardon;M. M. Mcgilchrist;A. D. Mckendrick;D. G. Mcdevitt

  • Socio-economic status, obesity and prevalence of Type 1 and Type 2 diabetes mellitus.

    Josie Evans;Ray W Newton;Danny A Ruta;Thomas M MacDonald

  • Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy

    Robert W. Flynn;Sandra R. Bonellie;Roland T. Jung;Thomas M. MacDonald

  • Nebivolol Reverses Endothelial Dysfunction in Essential Hypertension A Randomized, Double-Blind, Crossover Study

    Nikolaos Tzemos;Pitt O. Lim;Thomas M. MacDonald

  • Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

    T. M. MacDonald;S. V. Morant;G. C. Robinson;M. J. Shield

  • The diabetes audit and research in Tayside Scotland (darts) study: electronic record linkage to create a diabetes register

    Andrew D. Morris;Douglas I R Boyle;Ritchie MacAlpine;Alistair Emslie-Smith

  • Echocardiography in chronic heart failure in the community

    N.M. Wheeldon;T.M. MacDONALD;C.J. Flucker;A.D. McKENDRICK

  • Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database.

    Josie M M Evans;Ray W Newton;Danny A Ruta;Thomas M MacDonald

  • Adherence to statin treatment and readmission of patients after myocardial infarction: a six year follow up study

    L Wei;J Wang;P Thompson;S Wong

  • Incidence and prevalence of multiple sclerosis in the UK 1990–2010: a descriptive study in the General Practice Research Database

    I S Mackenzie;S V Morant;G A Bloomfield;T M MacDonald

  • High prevalence of primary aldosteronism in the Tayside hypertension clinic population.

    Pitt O. Lim;E. Dow;G. Brennan;R. T. Jung

  • Review of aldosterone- and angiotensin II-induced target organ damage and prevention

    Allan D Struthers;Thomas M MacDonald

  • Potentially high prevalence of primary aldosteronism in a primary-care population

    Pitt O Lim;Paula Rodgers;Kate Cardale;Alexander D Watson

  • Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease.

    Josie Evans;Alex McMahon;Frank E Murray;Denis G McDevitt

Frequent Co-Authors

Allan D. Struthers
Allan D. Struthers University of Dundee
Andrew D. Morris
Andrew D. Morris University of Edinburgh
Peter T. Donnan
Peter T. Donnan University of Dundee
Ian Ford
Ian Ford University of Glasgow
Alex S. F. Doney
Alex S. F. Doney University of Dundee
Morris J. Brown
Morris J. Brown Queen Mary University of London
Bryan Williams
Bryan Williams University College London
David J. Webb
David J. Webb University of Edinburgh
Gordon D. Murray
Gordon D. Murray University of Edinburgh
Peter S. Sever
Peter S. Sever Imperial College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative online degrees and career pathways in healthcare can open doors to rewarding opportunities, even for those not pursuing traditional medical school. For instance, students interested in administrative or non-clinical roles might consider training at the best medical billing and coding schools online, which often offer flexible schedules and the possibility of financial aid.

Those drawn to direct patient care, but seeking a quicker entry point, may look at lpn program no entrance exam options. These programs allow aspiring nurses to bypass standardized testing requirements, streamlining the admission process.

Leadership-minded students can accelerate their journey into healthcare management by enrolling in healthcare administration degree programs, available fully online for maximum convenience.

For registered nurses considering advanced practice roles, the asn to fnp programs offer seamless bridge opportunities to become a family nurse practitioner without repeating undergraduate coursework.

Best Scientists Citing Thomas M. MacDonald

Trending Scientists

Recently Published Articles